AlphaFold predicted structure
ARHGEF9 · O43307

Mean pLDDT
80.1/ 100
Confident
516 residues
Confidence breakdown
- Very high(≥ 90)53%
- Confident(70–90)24%
- Low(50–70)7%
- Very low(< 50)17%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
Cdc42 guanine nucleotide exchange factor 9
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Early onset or syndromic epilepsy
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Intellectual disability
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)developmental and epileptic encephalopathy, 8
Hyperekplexia - epilepsy
hereditary disease
X-linked intellectual disability - epilepsy
X-linked complex neurodevelopmental disorder
Global developmental delay
Seizure
developmental disability
Neurodevelopmental delay
alopecia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Rho guanine nucleotide exchange factor 9
Acts as a guanine nucleotide exchange factor (GEF) for CDC42. Promotes formation of GPHN clusters (By similarity)
ARHGEF9 · O43307

Mean pLDDT
80.1/ 100
Confident
516 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0